Displaying 6 results:

Safety, pharmacokinetics and pharmacodynamics of selgantolimod, an oral Toll-like receptor 8 agonist: a Phase Ia study in healthy subjects

Maribel Reyes, Justin D Lutz, Audrey H Lau, Anuj Gaggar, Ethan P Grant, Adarsh Joshi, Richard L Mackman, John Ling, Susanna K Tan, Natarajan Ayithan, Stephane Daffis, Jacky Woo, Peiwen Wu, Tina Lam, Simon P Fletcher, Shyamasundaran Kottilil, Bhawna Poonia, Edward J Gane, Anita Mathias, Polina German

Activation of HIV-specific CD8⁺ T-cells from HIV+ donors by vesatolimod

Renee R Ram, Paul Duatschek, Nicolas Margot, Michael Abram, Romas Geleziunas, Joseph Hesselgesser, Christian Callebaut

Antiviral activity of PLK1-targeting siRNA delivered by lipid nanoparticles in HBV-infected hepatocytes

Adrien Foca, Ammen Dhillon, Thomas Lahlali, Julie Lucifora, Anna Salvetti, Michel Rivoire, Amy Lee, David Durantel

Factors influencing hair lamivudine concentration among people living with HIV in Guangxi, China

Quan Zhang, Xiaoming Li, Shan Qiao, Zhiyong Shen, Yuejiao Zhou

Survival after long-term ART exposure: findings from an Asian patient population retained in care beyond 5 years on ART

Rimke Bijker, Sasisopin Kiertiburanakul, Nagalingeswaran Kumarasamy, Sanjay Pujari, Ly P Sun, Oon T Ng, Man P Lee, Jun Y Choi, Kinh V Nguyen, Yu J Chan, Tuti P Merati, Do D Cuong, Jeremy Ross, Awachana Jiamsakul, IeDEA Asia-Pacific

HBV flare associated with immunosuppressive treatments: it is still dangerous in the third-generation antivirals era

Bilal Toka, Aydin Seref Koksal, Gülşen İskender, Erol Çakmak, Oğuz Üsküdar, Mesut Sezikli, Göktuğ Şirin, Abdullah Emre Yildirim, Sami Fidan, Şencan Acar, Ahmet Tarik Eminler, Mustafa Ihsan Uslan, Sadettin Hülagü